Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study-Reference-Cited by-同舟云学术

Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study

Published:2017-10-18 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Valdés-Ferrer Sergio I.,Crispín José C.,Belaunzarán-Zamudio Pablo F.,Rodríguez-Osorio Carlos A.,Cacho-Díaz Bernardo,Alcocer-Varela Jorge,Cantú-Brito Carlos,Sierra-Madero Juan

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference29 articles.

1. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease;Autran;Science,1997

2. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation;Pakker;Nat Med,1998

3. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study;Kaufmann;Arch Intern Med,2003

4. Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection;Corbeau;Blood,2011

5. Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy;Moore;J Acquir Immune Defic Syndr,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from CD71 presentation and serum lipid peroxidation in myasthenia gravis – A small cohort study;International Immunopharmacology;2024-10

2. Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4;Brain Communications;2022-12-09

3. Cholinergic dysfunction in COVID-19: frantic search and hoping for the best;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-12-03

4. Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial;Molecular Medicine;2022-11-08

5. Neuropathogenesis of HIV and emerging therapeutic targets;Expert Opinion on Therapeutic Targets;2022-07-03